Skip to main content
Top
Published in: AIDS and Behavior 9/2019

01-09-2019 | Opioids | Original Paper

Implementing an Updated “Break the Cycle” Intervention to Reduce Initiating Persons into Injecting Drug Use in an Eastern European and a US “opioid epidemic” Setting

Authors: Don Des Jarlais, Anneli Uuskula, Ave Talu, David M. Barnes, Mait Raag, Kamyar Arasteh, Greete Org, Donna Demarest, Jonathan Feelemyer, Hayley Berg, Susan Tross

Published in: AIDS and Behavior | Issue 9/2019

Login to get access

Abstract

We tested the hypothesis that an updated “Break the Cycle” (BtC) intervention, based in social cognitive theory and motivational interviewing, would reduce the likelihood that current persons who inject drugs (PWID) would assist persons who do not inject drugs (non-PWID) with first injections in Tallinn, Estonia and Staten Island, New York City. 402 PWID were recruited, a baseline interview covering demographics, drug use, and assisting non-PWID with first drug injections was administered, followed by BtC intervention. 296 follow-up interviews were conducted 6 months post-intervention. Percentages assisting with first injections declined from 4.7 to 1.3% (73% reduction) in Tallinn (p < 0.02), and from 15 to 6% (60% reduction) in Staten Island (p < 0.05). Persons assisted with first injections declined from 11 to 3 in Tallinn (p = 0.02) and from 32 to 13 in Staten Island. (p = 0.024). Further implementation research on BtC interventions is urgently needed where injecting drug use is driving HIV/HCV epidemics and areas experiencing opioid epidemics.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gossop M, Griffiths P, Powis B, Strang J. Severity of dependence and route of administration of heroin, cocaine and amphetamines. Br J Addict. 1992;87(11):1527–36.CrossRef Gossop M, Griffiths P, Powis B, Strang J. Severity of dependence and route of administration of heroin, cocaine and amphetamines. Br J Addict. 1992;87(11):1527–36.CrossRef
2.
go back to reference Mateu-Gelabert P, Guarino H, Jessell L, Teper A. Injection and sexual HIV/HCV risk behaviors associated with nonmedical use of prescription opioids among young adults in New York City. J Subst Abuse Treat. 2015;48(1):13–20.CrossRef Mateu-Gelabert P, Guarino H, Jessell L, Teper A. Injection and sexual HIV/HCV risk behaviors associated with nonmedical use of prescription opioids among young adults in New York City. J Subst Abuse Treat. 2015;48(1):13–20.CrossRef
3.
go back to reference Jones CM, Christensen A, Gladden RM. Increases in prescription opioid injection abuse among treatment admissions in the United States, 2004–2013. Drug Alcohol Depend. 2017;176:89–95.CrossRef Jones CM, Christensen A, Gladden RM. Increases in prescription opioid injection abuse among treatment admissions in the United States, 2004–2013. Drug Alcohol Depend. 2017;176:89–95.CrossRef
4.
go back to reference Mack KA, Jones CM, Ballesteros MF. Illicit drug use, illicit drug use disorders, and drug overdose deaths in metropolitan and nonmetropolitan areas—United States. Am J Transplant. 2017;17(12):3241–52.CrossRef Mack KA, Jones CM, Ballesteros MF. Illicit drug use, illicit drug use disorders, and drug overdose deaths in metropolitan and nonmetropolitan areas—United States. Am J Transplant. 2017;17(12):3241–52.CrossRef
5.
go back to reference Des Jarlais DC, Casriel C, Friedman SR, Rosenblum A. AIDS and the transition to illicit drug injection: results of a randomized trial prevention program. Br J Addiction. 1992;87:493–8.CrossRef Des Jarlais DC, Casriel C, Friedman SR, Rosenblum A. AIDS and the transition to illicit drug injection: results of a randomized trial prevention program. Br J Addiction. 1992;87:493–8.CrossRef
6.
go back to reference Vlahov D, Fuller CM, Ompad DC, Galea S, Des Jarlais DC. Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health. 2004;81(1):14–9.CrossRef Vlahov D, Fuller CM, Ompad DC, Galea S, Des Jarlais DC. Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health. 2004;81(1):14–9.CrossRef
7.
go back to reference Werb D, Bluthenthal RN, Kolla G, et al. Preventing injection drug use initiation: state of the evidence and opportunities for the future. J Urban Health. 2018;95(1):91–8.CrossRef Werb D, Bluthenthal RN, Kolla G, et al. Preventing injection drug use initiation: state of the evidence and opportunities for the future. J Urban Health. 2018;95(1):91–8.CrossRef
8.
go back to reference Kermode M, Longleng V, Singh BC, Hocking J, Langkham B, Crofts N. My first time: initiation into injecting drug use in Manipur and Nagaland, north-east India. Harm Reduct J. 2007;4:19.CrossRef Kermode M, Longleng V, Singh BC, Hocking J, Langkham B, Crofts N. My first time: initiation into injecting drug use in Manipur and Nagaland, north-east India. Harm Reduct J. 2007;4:19.CrossRef
9.
go back to reference Rotondi NK, Strike C, Kolla G, et al. Transition to injection drug use: the role of initiators. AIDS Beh. 2014;18(3):486–94.CrossRef Rotondi NK, Strike C, Kolla G, et al. Transition to injection drug use: the role of initiators. AIDS Beh. 2014;18(3):486–94.CrossRef
10.
go back to reference Hunt N, Stillwell G, Taylor C, Griffiths P. Evaluation of a brief intervention to prevent initiation into injecting drugs. Drugs. 1998;5(2):185–94. Hunt N, Stillwell G, Taylor C, Griffiths P. Evaluation of a brief intervention to prevent initiation into injecting drugs. Drugs. 1998;5(2):185–94.
11.
go back to reference Strike C, Rotondi M, Kolla G, et al. Interrupting the social processes linked with initiation of injection drug use: results from a pilot study. Drug Alcohol Depend. 2014;137:48–54.CrossRef Strike C, Rotondi M, Kolla G, et al. Interrupting the social processes linked with initiation of injection drug use: results from a pilot study. Drug Alcohol Depend. 2014;137:48–54.CrossRef
12.
go back to reference Uuskula A, Kalikova A, Zilmer K, Tammai L, DeHovitz J. The role of injection drug use in the emergence of human immunodeficiency virus infection in Estonia. Int J Infect Dis. 2002;6(1):23–7.CrossRef Uuskula A, Kalikova A, Zilmer K, Tammai L, DeHovitz J. The role of injection drug use in the emergence of human immunodeficiency virus infection in Estonia. Int J Infect Dis. 2002;6(1):23–7.CrossRef
13.
go back to reference Uuskula A, Kals M, Rajaleid K, et al. High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs. J Public Health (Oxf). 2008;30(2):119–25.CrossRef Uuskula A, Kals M, Rajaleid K, et al. High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs. J Public Health (Oxf). 2008;30(2):119–25.CrossRef
14.
go back to reference EMCDDA. European drug report: trends and developments. Luxembourg: European Union: The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 2017. EMCDDA. European drug report: trends and developments. Luxembourg: European Union: The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 2017.
15.
go back to reference Uusküla A, Des Jarlais DC, Raag M, Pinkerton SD, Feelemyer J. Combined prevention for persons who inject drugs in the HIV epidemic in a transitional country: the case of Tallinn, Estonia. AIDS Care. 2015;27(1):105–11.CrossRef Uusküla A, Des Jarlais DC, Raag M, Pinkerton SD, Feelemyer J. Combined prevention for persons who inject drugs in the HIV epidemic in a transitional country: the case of Tallinn, Estonia. AIDS Care. 2015;27(1):105–11.CrossRef
16.
go back to reference Uuskula A, Rajaleid K, Talu A, Abel-Ollo K, Des Jarlais DC. A decline in the prevalence of injecting drug users in Estonia, 2005–2009. Int J Drug Policy. 2013;24:312–8.CrossRef Uuskula A, Rajaleid K, Talu A, Abel-Ollo K, Des Jarlais DC. A decline in the prevalence of injecting drug users in Estonia, 2005–2009. Int J Drug Policy. 2013;24:312–8.CrossRef
17.
go back to reference Uusküla A, Barnes DM, Raag M, Talu A, Tross S, Des Jarlais DC. Frequency and factors associated with providing injection initiation assistance in Tallinn, Estonia. Drug Alcohol Depend. 2018;188:64–70.CrossRef Uusküla A, Barnes DM, Raag M, Talu A, Tross S, Des Jarlais DC. Frequency and factors associated with providing injection initiation assistance in Tallinn, Estonia. Drug Alcohol Depend. 2018;188:64–70.CrossRef
18.
go back to reference NYC Department of Planning. Current population estimates. New York, NY: NYC Department of Planning; 2017. NYC Department of Planning. Current population estimates. New York, NY: NYC Department of Planning; 2017.
19.
go back to reference United States Census Bureau. 2010 Census Summary File 1: Population density by county. 2010. United States Census Bureau. 2010 Census Summary File 1: Population density by county. 2010.
20.
go back to reference NYC Department of Planning. DP03: Selected Economic Characteristics; 2015 American Community Survey 1-Year Estimates, New York City and Boroughs 2016. NYC Department of Planning. DP03: Selected Economic Characteristics; 2015 American Community Survey 1-Year Estimates, New York City and Boroughs 2016.
21.
go back to reference NYC Department of Planning. DP05: ACS Demographic and Housing Estimates; 2015 American 812 Community Survey 1-Year Estimates, New York City and Boroughs 2016. NYC Department of Planning. DP05: ACS Demographic and Housing Estimates; 2015 American 812 Community Survey 1-Year Estimates, New York City and Boroughs 2016.
24.
go back to reference Luszczynska A, Schwarzer R. Social cognitive theory. In: Conner M, Norman P, editors. Predicting health behaviour. California: University of California; 2005. p. 127–69. Luszczynska A, Schwarzer R. Social cognitive theory. In: Conner M, Norman P, editors. Predicting health behaviour. California: University of California; 2005. p. 127–69.
25.
go back to reference Bandura A. Social cognitive theory and exercise of control over HIV infection. In: Peterson J, DiClemente R, editors. Preventing AIDS: theory and practice of behavioral interventions. New York: Plenum Press; 1993. Bandura A. Social cognitive theory and exercise of control over HIV infection. In: Peterson J, DiClemente R, editors. Preventing AIDS: theory and practice of behavioral interventions. New York: Plenum Press; 1993.
26.
go back to reference Miller WR, Rollnick S. Motivational interviewing: helping people change. New York: Guilford Press; 2012. Miller WR, Rollnick S. Motivational interviewing: helping people change. New York: Guilford Press; 2012.
27.
go back to reference Heckathorn D. Respondent-driven sampling: A new approach to the study of hidden populations. Soc Problems. 1997;44(2):174–99.CrossRef Heckathorn D. Respondent-driven sampling: A new approach to the study of hidden populations. Soc Problems. 1997;44(2):174–99.CrossRef
28.
go back to reference Heckathorn D, Semaan S, Broadhead RS, Hughes J. Extensions of respondent-driven sampling: a new approach to the study of injection drug users aged 18–25. AIDS Behav. 2002;6(1):55–67.CrossRef Heckathorn D, Semaan S, Broadhead RS, Hughes J. Extensions of respondent-driven sampling: a new approach to the study of injection drug users aged 18–25. AIDS Behav. 2002;6(1):55–67.CrossRef
29.
go back to reference Uuskula A, Heimer R, Dehovitz J, Fischer K, McNutt LA. Surveillance of HIV, hepatitis B virus, and hepatitis C virus in an estonian injection drug-using population: sensitivity and specificity of testing syringes for public health surveillance. J Infect Dis. 2006;193(3):455–7.CrossRef Uuskula A, Heimer R, Dehovitz J, Fischer K, McNutt LA. Surveillance of HIV, hepatitis B virus, and hepatitis C virus in an estonian injection drug-using population: sensitivity and specificity of testing syringes for public health surveillance. J Infect Dis. 2006;193(3):455–7.CrossRef
30.
go back to reference Uuskula A, McNutt LA, Dehovitz J, Fischer K, Heimer R. High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia. Int J STD AIDS. 2007;18(1):41–6.CrossRef Uuskula A, McNutt LA, Dehovitz J, Fischer K, Heimer R. High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia. Int J STD AIDS. 2007;18(1):41–6.CrossRef
31.
go back to reference Des Jarlais DC, Perlis TE, Stimson GV, Poznyak V, Group WPIDICS. Using standardization methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO drug injection study phase II. BMC Public Health. 2006;654:6–12. Des Jarlais DC, Perlis TE, Stimson GV, Poznyak V, Group WPIDICS. Using standardization methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO drug injection study phase II. BMC Public Health. 2006;654:6–12.
32.
go back to reference StataCorp. Stata Statistical Software: Release 14. College Station, TX: StataCorp LP; 2015. StataCorp. Stata Statistical Software: Release 14. College Station, TX: StataCorp LP; 2015.
33.
go back to reference Harrison L, Hughes A. The validity of self-reported drug use: Improving the accuracy of survey estimates (NIH Publication No. 97-4147, NIDA Research Monograph 167). Rockville, MD: National Institute on Drug Abuse. 1997. Harrison L, Hughes A. The validity of self-reported drug use: Improving the accuracy of survey estimates (NIH Publication No. 97-4147, NIDA Research Monograph 167). Rockville, MD: National Institute on Drug Abuse. 1997.
34.
go back to reference Napper LE, Fisher DG, Johnson ME, Wood MM. The reliability and validity of drug users’ self reports of amphetamine use among primarily heroin and cocaine users. Addict Behav. 2010;35(4):350–4.CrossRef Napper LE, Fisher DG, Johnson ME, Wood MM. The reliability and validity of drug users’ self reports of amphetamine use among primarily heroin and cocaine users. Addict Behav. 2010;35(4):350–4.CrossRef
35.
go back to reference Kolla G, Strike C, Roy É, et al. Initiation stories: an examination of the narratives of people who assist with a first injection. Subst Use Misuse. 2015;50(13):1619–27.CrossRef Kolla G, Strike C, Roy É, et al. Initiation stories: an examination of the narratives of people who assist with a first injection. Subst Use Misuse. 2015;50(13):1619–27.CrossRef
36.
go back to reference Wenger LD, Lopez AM, Kral AH, Bluthenthal RN. Moral ambivalence and the decision to initiate others into injection drug use: a qualitative study in two California cities. Int J Drug Policy. 2016;37:42–51.CrossRef Wenger LD, Lopez AM, Kral AH, Bluthenthal RN. Moral ambivalence and the decision to initiate others into injection drug use: a qualitative study in two California cities. Int J Drug Policy. 2016;37:42–51.CrossRef
37.
go back to reference Des Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348(9033):987–91.CrossRef Des Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348(9033):987–91.CrossRef
38.
go back to reference Uuskula A, Des Jarlais DC, Kals M, et al. Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia. BMC Public Health. 2011;11:517.CrossRef Uuskula A, Des Jarlais DC, Kals M, et al. Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia. BMC Public Health. 2011;11:517.CrossRef
39.
go back to reference Casriel C, Des Jarlais DC, Rodriguez R, Friedman SR, Stepherson B, Khuri E. Working with heroin sniffers: clinical issues in preventing drug injection. J Subst Abuse Treat. 1990;7:1–10.CrossRef Casriel C, Des Jarlais DC, Rodriguez R, Friedman SR, Stepherson B, Khuri E. Working with heroin sniffers: clinical issues in preventing drug injection. J Subst Abuse Treat. 1990;7:1–10.CrossRef
Metadata
Title
Implementing an Updated “Break the Cycle” Intervention to Reduce Initiating Persons into Injecting Drug Use in an Eastern European and a US “opioid epidemic” Setting
Authors
Don Des Jarlais
Anneli Uuskula
Ave Talu
David M. Barnes
Mait Raag
Kamyar Arasteh
Greete Org
Donna Demarest
Jonathan Feelemyer
Hayley Berg
Susan Tross
Publication date
01-09-2019
Publisher
Springer US
Published in
AIDS and Behavior / Issue 9/2019
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-019-02467-y

Other articles of this Issue 9/2019

AIDS and Behavior 9/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.